{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Deciphera Pharmaceuticals", "item": "https://www.patentleaderboard.com/2021/company/deciphera-pharmaceuticals"}, {"@type": "ListItem", "position": 4, "name": "Michael D. Kaufman", "item": "https://www.patentleaderboard.com/2021/inventor/fl:mi_ln:kaufman-12"}]}

Home › 2021 › Deciphera Pharmaceuticals › Michael D. Kaufman

Michael D. Kaufman — 2 Patents in 2021

DPDeciphera Pharmaceuticals: 2 patents #1 of 11Top 10%

Waltham, MA: #43 of 326 inventorsTop 15%

Massachusetts: #2,417 of 14,123 inventorsTop 20%

Overall (2021): #130,439 of 548,734Top 25%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11185535	Amorphous kinase inhibitor formulations and methods of use thereof	Scott Bone, Corey Bloom, Fred Jordan	2021-11-30	$10,356,000
RE48731	Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases	Daniel L. Flynn, Peter A. Petillo	2021-09-14

Michael D. Kaufman — 2 Patents in 2021

Issued Patents 2021

Patent Widget